The use of <sup>68</sup> Ga‐PSMA PET/CT to stratify patients with PI‐RADS 3 lesions according to clinically significant prostate cancer risk-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The use of ⁶⁸ Ga‐PSMA PET/CT to stratify patients with PI‐RADS 3 lesions according to clinically significant prostate cancer risk

Published:2022-12-21 Issue:5 Volume:83 Page:430-439
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Yang Jinhui¹,Tang Yongxiang¹^ORCID,Zhou Chuanchi²,Zhou Ming¹,Li Jian¹,Hu Shuo¹³⁴^ORCID

Affiliation:

1. Department of Nuclear Medicine Xiangya Hospital, Central South University Changsha Hunan China

2. Department of Urology Xiangya Hospital, Central South University Changsha Hunan China

3. Key Laboratory of Biological Nanotechnology of National Health Commission, Xiangya Hospital, Central South University Changsha Hunan China

4. National Clinical Research Center for Geriatric Disorders (XIANGYA), Xiangya Hospital, Central South University Changsha Hunan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24475

Reference36 articles.

1. Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer

2. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2

3. Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer

4. Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate Cancer

5. Impact of PI-RADS Category 3 lesions on the diagnostic accuracy of MRI for detecting prostate cancer and the prevalence of prostate cancer within each PI-RADS category: A systematic review and meta-analysis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and diffusion features for identification of clinically significant prostate cancer in PI-RADS 3 lesions;Urologic Oncology: Seminars and Original Investigations;2024-11

2. Enhancing prostate cancer diagnosis and reducing unnecessary biopsies with [18F]DCFPyL PET/CT imaging in PI-RADS 3/4 patients;Scientific Reports;2024-07-05

3. The Value of⁶⁸Ga-PSMA PET/MRI for Classifying Patients with PI-RADS 3 Lesions on Multiparametric MRI: A Prospective Single-Center Study;Journal of Nuclear Medicine;2024-03-14

4. Clinical and Radiological Factors for Predicting Clinically Significant Prostate Cancer in Biopsy-Naive Patients With PI-RADS 3 Lesions;Technology in Cancer Research & Treatment;2024-01

5. Management Strategy for Prostate Imaging Reporting and Data System Category 3 Lesions;Current Urology Reports;2023-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3